105 related articles for article (PubMed ID: 18316625)
21. Tumor necrosis factor-alpha and CD95 ligation suppress erythropoiesis in Fanconi anemia C gene knockout mice.
Otsuki T; Nagakura S; Wang J; Bloom M; Grompe M; Liu JM
J Cell Physiol; 1999 Apr; 179(1):79-86. PubMed ID: 10082135
[TBL] [Abstract][Full Text] [Related]
22. TEMPOL protects against lens DNA strand breaks and cataract in the x-rayed rabbit.
Sasaki H; Lin LR; Yokoyama T; Sevilla MD; Reddy VN; Giblin FJ
Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):544-52. PubMed ID: 9501865
[TBL] [Abstract][Full Text] [Related]
23. Prevention of catecholaminergic oxidative toxicity by 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl and its recycling complex with polynitroxylated albumin, TEMPOL/PNA.
Weinberg A; Nylander KD; Yan C; Ma L; Hsia CJ; Tyurin VA; Kagan VE; Schor NF
Brain Res; 2004 Jun; 1012(1-2):13-21. PubMed ID: 15158156
[TBL] [Abstract][Full Text] [Related]
24. Effects of tempol and redox-cycling nitroxides in models of oxidative stress.
Wilcox CS
Pharmacol Ther; 2010 May; 126(2):119-45. PubMed ID: 20153367
[TBL] [Abstract][Full Text] [Related]
25. Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats.
García-Calderó H; Rodríguez-Vilarrupla A; Gracia-Sancho J; Diví M; Laviña B; Bosch J; García-Pagán JC
J Hepatol; 2011 Apr; 54(4):660-5. PubMed ID: 21159403
[TBL] [Abstract][Full Text] [Related]
26. TEMPOL protects human neuroblastoma SH-SY5Y cells against β-amyloid-induced cell toxicity.
Chonpathompikunlert P; Han J; Toh K; Isoda H; Nagasaki Y
Eur J Pharmacol; 2011 Jan; 650(2-3):544-9. PubMed ID: 20969847
[TBL] [Abstract][Full Text] [Related]
27. The nitroxide Tempol affords protection against ultraviolet radiation in a transgenic murine fibroblast culture model of cutaneous photoaging.
Bernstein EF; Kong SK; Brown DB; Kwak BC; Takeuchi T; Gasparro FP; Uitto J
Exp Dermatol; 2001 Feb; 10(1):55-61. PubMed ID: 11168580
[TBL] [Abstract][Full Text] [Related]
28. Tempol inhibits neutrophil and hydrogen peroxide-mediated DNA damage.
Hahn SM; Mitchell JB; Shacter E
Free Radic Biol Med; 1997; 23(6):879-84. PubMed ID: 9378367
[TBL] [Abstract][Full Text] [Related]
29. In vivo repopulation ability of genetically corrected bone marrow cells from Fanconi anemia patients.
Cohen-Haguenauer O; Péault B; Bauche C; Daniel MT; Casal I; Levy V; Dausset J; Boiron M; Auclair C; Gluckman E; Marty M
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2340-5. PubMed ID: 16461901
[TBL] [Abstract][Full Text] [Related]
30. Evidence for complete epistasis of null mutations in murine Fanconi anemia genes Fanca and Fancg.
van de Vrugt HJ; Koomen M; Bakker S; Berns MA; Cheng NC; van der Valk MA; de Vries Y; Rooimans MA; Oostra AB; Hoatlin ME; Te Riele H; Joenje H; Arwert F
DNA Repair (Amst); 2011 Dec; 10(12):1252-61. PubMed ID: 22036606
[TBL] [Abstract][Full Text] [Related]
31. Double-edged action of SOD mimetic in diabetic nephropathy.
Asaba K; Tojo A; Onozato ML; Goto A; Fujita T
J Cardiovasc Pharmacol; 2007 Jan; 49(1):13-9. PubMed ID: 17261958
[TBL] [Abstract][Full Text] [Related]
32. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
[TBL] [Abstract][Full Text] [Related]
33. Different protective actions of losartan and tempol on the renal inflammatory response to acute sodium overload.
Rosón MI; Della Penna SL; Cao G; Gorzalczany S; Pandolfo M; Toblli JE; Fernández BE
J Cell Physiol; 2010 Jul; 224(1):41-8. PubMed ID: 20232302
[TBL] [Abstract][Full Text] [Related]
34. A low molecular weight antioxidant decreases weight and lowers tumor incidence.
Mitchell JB; Xavier S; DeLuca AM; Sowers AL; Cook JA; Krishna MC; Hahn SM; Russo A
Free Radic Biol Med; 2003 Jan; 34(1):93-102. PubMed ID: 12498984
[TBL] [Abstract][Full Text] [Related]
35. Ascorbic acid decreases oxidant stress in endothelial cells caused by the nitroxide tempol.
May JM; Qu ZC; Juliao S; Cobb CE
Free Radic Res; 2005 Feb; 39(2):195-202. PubMed ID: 15763967
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of oxygen-dependent radiation-induced damage by the nitroxide superoxide dismutase mimic, tempol.
Mitchell JB; DeGraff W; Kaufman D; Krishna MC; Samuni A; Finkelstein E; Ahn MS; Hahn SM; Gamson J; Russo A
Arch Biochem Biophys; 1991 Aug; 289(1):62-70. PubMed ID: 1654848
[TBL] [Abstract][Full Text] [Related]
37. Antioxidant enzymes and effects of tempol on the development of hypertension induced by nitric oxide inhibition.
Sainz J; Wangensteen R; Rodríguez Gómez I; Moreno JM; Chamorro V; Osuna A; Bueno P; Vargas F
Am J Hypertens; 2005 Jun; 18(6):871-7. PubMed ID: 15925750
[TBL] [Abstract][Full Text] [Related]
38. The effects of Tempol on ferritin synthesis and Fe metabolism in lens epithelial cells.
Goralska M; Holley B; McGahan MC
Biochim Biophys Acta; 2000 Jun; 1497(1):51-60. PubMed ID: 10838158
[TBL] [Abstract][Full Text] [Related]
39. Systemic DNA damage accumulation under in vivo tumor growth can be inhibited by the antioxidant Tempol.
Georgakilas AG; Redon CE; Ferguson NF; Kryston TB; Parekh P; Dickey JS; Nakamura AJ; Mitchell JB; Bonner WM; Martin OA
Cancer Lett; 2014 Oct; 353(2):248-57. PubMed ID: 25069035
[TBL] [Abstract][Full Text] [Related]
40. Differential radiation protection of salivary glands versus tumor by Tempol with accompanying tissue assessment of Tempol by magnetic resonance imaging.
Cotrim AP; Hyodo F; Matsumoto K; Sowers AL; Cook JA; Baum BJ; Krishna MC; Mitchell JB
Clin Cancer Res; 2007 Aug; 13(16):4928-33. PubMed ID: 17699873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
